Viewing Study NCT04083534


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-02-22 @ 5:09 PM
Study NCT ID: NCT04083534
Status: COMPLETED
Last Update Posted: 2025-05-30
First Post: 2019-08-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)
Sponsor: Regeneron Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Multiple Myeloma View
None Refractory Multiple Myeloma View
Keywords: